Sangamo Therapeutics (SGMO) Misses Q1 EPS by 71c, Miss on Revenues
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: -5.7%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q1 EPS of ($0.23), $0.71 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $12.64 million versus the consensus estimate of $53.09 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
- After-Hours Stock Movers: AVAV, PRAX, VSH, CNXC, SHAZ
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
